Agilent Technologies, Inc. $A Holdings Increased by S.E.E.D. Planning Group LLC

Key Points

• S.E.E.D. Planning Group LLC increased its stake in Agilent Technologies by 13.3% in Q2, making it the firm's 8th largest position, valued at approximately $12.25 million.
• Insider activity includes CEO Padraig McDonnell selling 1,508 shares at an average price of $117.44, reducing his ownership to 37,448 shares.
• Agilent's latest quarterly earnings reported an EPS of $1.37, meeting expectations, with a revenue increase of 10.1% from the previous year.

S.E.E.D. Planning Group LLC increased its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 13.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 103,814 shares of the medical research company's stock after purchasing an additional 12,181 shares during the quarter. Agilent Technologies makes up approximately 3.8% of S.E.E.D. Planning Group LLC's holdings, making the stock its 8th largest holding. S.E.E.D. Planning Group LLC's holdings in Agilent Technologies were worth $12,251,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of A. Brighton Jones LLC boosted its position in Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after acquiring an additional 270 shares in the last quarter. Nomura Holdings Inc. bought a new stake in Agilent Technologies during the 4th quarter valued at approximately $1,272,000. Rafferty Asset Management LLC boosted its position in Agilent Technologies by 10.1% during the 4th quarter. Rafferty Asset Management LLC now owns 32,580 shares of the medical research company's stock valued at $4,377,000 after acquiring an additional 2,987 shares in the last quarter. Royal Bank of Canada boosted its position in Agilent Technologies by 4.9% during the 4th quarter. Royal Bank of Canada now owns 834,041 shares of the medical research company's stock valued at $112,045,000 after acquiring an additional 39,321 shares in the last quarter. Finally, Toronto Dominion Bank boosted its position in Agilent Technologies by 5.8% during the 4th quarter. Toronto Dominion Bank now owns 153,898 shares of the medical research company's stock valued at $20,674,000 after acquiring an additional 8,420 shares in the last quarter. 87.41% of the stock is owned by institutional investors.

Agilent Technologies Stock Performance

A traded down $0.93 during mid-day trading on Friday, reaching $126.70. 590,335 shares of the company traded hands, compared to its average volume of 1,939,619. The stock has a market capitalization of $35.92 billion, a P/E ratio of 29.74, a P/E/G ratio of 3.94 and a beta of 1.24. The company has a quick ratio of 1.71, a current ratio of 2.25 and a debt-to-equity ratio of 0.53. The company's fifty day moving average price is $120.19 and its 200-day moving average price is $115.94. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last announced its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, meeting analysts' consensus estimates of $1.37. The business had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company's quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.32 EPS. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $0.99 annualized dividend and a yield of 0.8%. Agilent Technologies's dividend payout ratio is currently 23.24%.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. Barclays reaffirmed an "equal weight" rating and set a $125.00 price objective on shares of Agilent Technologies in a research report on Friday, August 29th. Robert W. Baird lifted their price objective on Agilent Technologies from $141.00 to $142.00 and gave the company an "outperform" rating in a research report on Thursday, August 28th. Leerink Partners lifted their target price on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a report on Friday, May 30th. JPMorgan Chase & Co. lowered their target price on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a report on Thursday, May 29th. Finally, Evercore ISI lowered their target price on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating for the company in a report on Thursday, August 28th. Six research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to data from MarketBeat.com, Agilent Technologies presently has a consensus rating of "Moderate Buy" and an average target price of $140.08.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the company's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the completion of the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at approximately $4,397,893.12. This represents a 3.87% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.26% of the company's stock.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.